Zimmer Biomet
ZBH
#911
Rank
A$34.06 B
Marketcap
$171.11
Share price
1.24%
Change (1 day)
-3.47%
Change (1 year)
Categories

P/E ratio for Zimmer Biomet (ZBH)

P/E ratio as of December 2024 (TTM): 44.4

According to Zimmer Biomet's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 44.4481. At the end of 2022 the company had a P/E ratio of 116.

P/E ratio history for Zimmer Biomet from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202211681.37%
202163.9-129.05%
2020-220-934.17%
201926.4-148.71%
2018-54.1-520.52%
201712.9-80.85%
201667.2-38.56%
2015109321.44%
201426.028.88%
201320.234.19%
201215.016.97%
201112.8-26.59%
201017.51.48%
200917.263.81%
200810.5-46.27%
200719.6-11.74%
200622.20.3%
200522.1-36.87%
200435.0-14.9%
200341.234.83%
200230.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
53.5 20.45%๐Ÿ‡บ๐Ÿ‡ธ USA
16.8-62.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-18.7-142.07%๐Ÿ‡บ๐Ÿ‡ธ USA
31.8-28.38%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.